Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIMPATICO: Campath-1H vs ATG in SPK Transplantation
NCT00316810Phase 3Completed
- Start
- Apr 2006
- Primary completion
- Feb 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of alemtuzumab. Started Apr 2006; status: completed.
02
Drugs
alemtuzumab
Beyond the preview
Go deeper on NCT00316810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00316810.